Vaccination

EU agency starts review of France's Sanofi COVID jab

The European Medicines Agency said Tuesday it had started a "rolling review" of France's Sanofi coronavirus jab, which could lead to authorisation for use in the European Union.

Diseases, Conditions, Syndromes

Philippines halts sale of Sanofi's dengue vaccine (Update)

The Philippines has suspended the sale and distribution of Sanofi's dengue vaccine, authorities said Tuesday, after the French pharmaceutical giant last week warned it could worsen symptoms for people who had not previously ...

Medications

Sanofi wins big in battle for nano-drug maker

France's Sanofi announced Monday that it had reached a deal to acquire Belgian biotech firm Ablynx that values the firm at 3.9 billion euros ($4.8 billion), beating out Danish rival Novo Nordisk for the nano-drug maker.

Diseases, Conditions, Syndromes

Philippines probes deaths after dengue vaccine suspended

Philippine officials are investigating whether three deaths were linked to an anti-dengue vaccine that the country's regulators have suspended, health officials said Thursday.

Other

France's Sanofi opens research hub in China

French pharmaceutical giant Sanofi opened a research hub in Shanghai Thursday, the company said, as foreign drug firms face government scrutiny after drugmaker GlaxoSmithKline (GSK) was found guilty of bribery last week.

Health

Horsemeat linked to new food scandal seized in Belgium

Belgium health authorities on Friday reported the seizure of 16.8 tonnes of horsemeat, part of it linked to a fresh food scandal in France involving meat not supposed to wind up on people's plates.

Vaccination

Left-behind Sanofi closes in on Covid vaccine

French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine.

page 8 from 13